인쇄하기
취소

BMS Korea denies possible M&A as groundless

Published: 2003-06-24 06:59:00
Updated: 2003-06-24 06:59:00
BMS Korea dismissed an allegation that it is proceeding with the acquisition of a Korean pharmaceutical firm.

An official from BMS Korea said, "It is nothing but a rumor. The company has positively tried to seek a promising partner without resorting to M&A but any detailed plan to look into this matter has yet to be in inactive status. "The presidency is now vacant and the partnership issue ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.